Unity Biotechnology, Inc.·4

Nov 21, 5:35 PM ET

Dananberg Jamie 4

4 · Unity Biotechnology, Inc. · Filed Nov 21, 2022

Insider Transaction Report

Form 4
Period: 2022-11-18
Dananberg Jamie
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-11-18+65,00065,000 total
    Exercise: $2.38Exp: 2032-11-18Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]The underlying shares vest and become exercisable pursuant to the following schedule: One-eighth of the shares subject to the option vest in successive, equal quarterly installments starting on February 18, 2023, subject to the Reporting Person's continued service to Issuer through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION